Vicarious Surgical Inc. (RBOT)
NYSE: RBOT · Real-Time Price · USD
2.980
-0.020 (-0.67%)
At close: Dec 5, 2025, 4:00 PM EST
2.924
-0.056 (-1.87%)
After-hours: Dec 5, 2025, 7:40 PM EST
Vicarious Surgical Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Vicarious Surgical stock has a target of 7.00, which predicts a 134.90% increase from the current stock price of 2.98.
Price Target: $7.00 (+134.90%)
Analyst Consensus: Hold
* Price targets were last updated on Aug 13, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Vicarious Surgical is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Hold Maintains $8.5 → $7 | Hold | Maintains | $8.5 → $7 | +134.90% | Aug 13, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $11 → $8.5 | Hold | Maintains | $11 → $8.5 | +185.23% | Mar 18, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $12 → $11 | Hold | Maintains | $12 → $11 | +252.35% | Nov 13, 2024 |
| Piper Sandler | Piper Sandler | Hold Maintains $30 → $12 | Hold | Maintains | $30 → $12 | +302.68% | Aug 13, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $18 → $10 | Hold | Maintains | $18 → $10 | +235.57% | Jul 15, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-8.17
from -10.74
EPS Next Year
-4.61
from -8.17
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||
| Avg | n/a | n/a | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -7.90 | -4.27 | |
| Avg | -8.17 | -4.61 | |
| Low | -8.25 | -4.84 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.